HK1178155A1 - Novel synthesis for thiazolidinedione compounds - Google Patents
Novel synthesis for thiazolidinedione compoundsInfo
- Publication number
- HK1178155A1 HK1178155A1 HK13105164.4A HK13105164A HK1178155A1 HK 1178155 A1 HK1178155 A1 HK 1178155A1 HK 13105164 A HK13105164 A HK 13105164A HK 1178155 A1 HK1178155 A1 HK 1178155A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- novel synthesis
- thiazolidinedione compounds
- thiazolidinedione
- compounds
- synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/51—Acetal radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32550210P | 2010-04-19 | 2010-04-19 | |
| US32749810P | 2010-04-23 | 2010-04-23 | |
| PCT/US2011/032822 WO2011133442A1 (fr) | 2010-04-19 | 2011-04-18 | Nouvelle synthèse de thiazolidinediones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1178155A1 true HK1178155A1 (en) | 2013-09-06 |
Family
ID=44148625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13105164.4A HK1178155A1 (en) | 2010-04-19 | 2013-04-29 | Novel synthesis for thiazolidinedione compounds |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8937182B2 (fr) |
| EP (1) | EP2560956B1 (fr) |
| JP (1) | JP2013525355A (fr) |
| KR (1) | KR101781665B1 (fr) |
| CN (1) | CN102947269B (fr) |
| AU (1) | AU2011242956B2 (fr) |
| CA (1) | CA2796437C (fr) |
| DK (1) | DK2560956T3 (fr) |
| ES (1) | ES2610623T3 (fr) |
| HK (1) | HK1178155A1 (fr) |
| HU (1) | HUE030263T2 (fr) |
| MX (1) | MX2012012092A (fr) |
| NZ (1) | NZ602883A (fr) |
| PL (1) | PL2560956T3 (fr) |
| RU (1) | RU2012148908A (fr) |
| WO (1) | WO2011133442A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2585066B1 (fr) * | 2010-06-24 | 2018-09-26 | Alkermes Pharma Ireland Limited | Promédicaments de composés nh-acides : dérivés esters, carbonates, carbamates et phosphonates |
| PL2603498T3 (pl) * | 2010-08-10 | 2017-06-30 | Octeta Therapeutics, Llc | Nowa synteza związków tiazolidynodionu |
| MX342289B (es) | 2010-08-10 | 2016-09-23 | Metabolic Solutions Dev Company Llc * | Sintesis para compuestos de tiazolidindiona. |
| TW202246215A (zh) | 2015-12-18 | 2022-12-01 | 美商亞德利克斯公司 | 作為非全身ｔｇｒ５促效劑之經取代之４－苯基吡啶化合物 |
| US20210038566A1 (en) | 2018-02-08 | 2021-02-11 | Enyo Pharma | Use of modulators of neet proteins for the treatment of infection |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| US5143930A (en) | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| CA2106967C (fr) * | 1991-04-11 | 2003-12-09 | Takashi Sohda | Derives thiazolidinedione, leur production et leur utilisation |
| NO302471B1 (no) | 1991-12-26 | 1998-03-09 | Sankyo Co | Tiazolidinforbindelser og farmasöytisk preparat |
| JPH07188227A (ja) * | 1993-12-24 | 1995-07-25 | Japan Tobacco Inc | チアゾリジン誘導体及びオキサゾール誘導体 |
| SE9702305D0 (sv) | 1997-06-17 | 1997-06-17 | Astra Ab | New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives |
| AP869A (en) * | 1998-01-05 | 2000-09-04 | Pfizer | 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents. |
| US7407978B2 (en) | 1999-04-06 | 2008-08-05 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
| US6768008B2 (en) * | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| FR2817144B1 (fr) | 2000-11-29 | 2003-01-03 | Micro Mega Sa | Sequence d'instruments canalaires pour l'execution d'un protocole operatoire d'endodontie |
| WO2003029251A1 (fr) | 2001-09-28 | 2003-04-10 | Biocon Limited | Procede de synthese de derives thiazolidinedione |
| FR2861069B1 (fr) | 2003-10-17 | 2005-12-09 | Galderma Res & Dev | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
| NZ571870A (en) * | 2006-03-16 | 2011-07-29 | Metabolic Solutions Dev Co | Thiazolidinedione analogues for the treatment of hypertension and for lowering lipids |
| RU2445957C2 (ru) | 2006-03-16 | 2012-03-27 | Метаболик Солюшнз Девелопмент Компани | Аналоги тиазолидиндиона |
| JP2009530293A (ja) | 2006-03-16 | 2009-08-27 | メタボリック ソリューションズ ディベロップメント カンパニー | チアゾリジンジオン類似体およびグルココルチコイドアゴニストの併用療法 |
| AU2007326395B2 (en) * | 2006-12-01 | 2012-10-11 | Msd K.K. | Novel phenyl-isoxazol-3-ol derivative |
| WO2008118327A1 (fr) | 2007-03-23 | 2008-10-02 | University Of Toledo | Analogues d'épothilone restreints en conformation en tant qu'agents anti-leucémiques |
| PL2203433T3 (pl) | 2007-09-14 | 2013-04-30 | Metabolic Solutions Dev Co Llc | 5-(4-(2-(3-metoksyfenylo)-2-oksoetoksy)benzylo)tiazolidyno-2,4-dion do stosowania w leczeniu cukrzycy |
| WO2009148195A1 (fr) | 2008-06-02 | 2009-12-10 | Daebong Ls, Ltd. | Composé de 5(4-hydroxybenzyl)thiazolidine-2,4-dione comme produit intermédiaire dans la synthèse de composés à base de thiazolidinedione et procédé de préparation de celui-ci |
| CA2796872A1 (fr) | 2010-04-19 | 2011-10-27 | Metabolic Solutions Development Company, Llc | Nouvelle synthese pour des composes de thiazolidinedione |
| MX342289B (es) | 2010-08-10 | 2016-09-23 | Metabolic Solutions Dev Company Llc * | Sintesis para compuestos de tiazolidindiona. |
| PL2603498T3 (pl) | 2010-08-10 | 2017-06-30 | Octeta Therapeutics, Llc | Nowa synteza związków tiazolidynodionu |
-
2011
- 2011-04-18 HU HUE11716155A patent/HUE030263T2/en unknown
- 2011-04-18 NZ NZ602883A patent/NZ602883A/en not_active IP Right Cessation
- 2011-04-18 US US13/641,917 patent/US8937182B2/en active Active
- 2011-04-18 EP EP11716155.4A patent/EP2560956B1/fr active Active
- 2011-04-18 JP JP2013506202A patent/JP2013525355A/ja active Pending
- 2011-04-18 ES ES11716155.4T patent/ES2610623T3/es active Active
- 2011-04-18 DK DK11716155.4T patent/DK2560956T3/en active
- 2011-04-18 CA CA2796437A patent/CA2796437C/fr active Active
- 2011-04-18 MX MX2012012092A patent/MX2012012092A/es active IP Right Grant
- 2011-04-18 WO PCT/US2011/032822 patent/WO2011133442A1/fr active Application Filing
- 2011-04-18 AU AU2011242956A patent/AU2011242956B2/en not_active Ceased
- 2011-04-18 KR KR1020127030070A patent/KR101781665B1/ko active IP Right Grant
- 2011-04-18 RU RU2012148908/04A patent/RU2012148908A/ru not_active Application Discontinuation
- 2011-04-18 PL PL11716155T patent/PL2560956T3/pl unknown
- 2011-04-18 CN CN201180030253.8A patent/CN102947269B/zh not_active Expired - Fee Related
-
2013
- 2013-04-29 HK HK13105164.4A patent/HK1178155A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2796437C (fr) | 2018-09-11 |
| CN102947269A (zh) | 2013-02-27 |
| ES2610623T3 (es) | 2017-04-28 |
| DK2560956T3 (en) | 2017-01-23 |
| CN102947269B (zh) | 2015-11-25 |
| US20130204004A1 (en) | 2013-08-08 |
| EP2560956A1 (fr) | 2013-02-27 |
| CA2796437A1 (fr) | 2011-10-27 |
| PL2560956T3 (pl) | 2017-03-31 |
| JP2013525355A (ja) | 2013-06-20 |
| EP2560956B1 (fr) | 2016-10-26 |
| HUE030263T2 (en) | 2017-04-28 |
| AU2011242956A1 (en) | 2012-11-01 |
| US8937182B2 (en) | 2015-01-20 |
| NZ602883A (en) | 2014-09-26 |
| AU2011242956B2 (en) | 2015-01-22 |
| WO2011133442A1 (fr) | 2011-10-27 |
| MX2012012092A (es) | 2012-12-17 |
| RU2012148908A (ru) | 2014-05-27 |
| KR101781665B1 (ko) | 2017-09-25 |
| KR20130051945A (ko) | 2013-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201005589D0 (en) | Novel compounds | |
| GB201007203D0 (en) | Novel compounds | |
| SI2510089T1 (sl) | Sinteza prazolnih spojin | |
| GB201012686D0 (en) | Novel compounds | |
| HK1178155A1 (en) | Novel synthesis for thiazolidinedione compounds | |
| IL225451A0 (en) | A process for the synthesis of compounds containing a thio-triazolo group | |
| PL2603507T3 (pl) | Synteza związków tiazolidynodionu | |
| PL2603498T3 (pl) | Nowa synteza związków tiazolidynodionu | |
| GB201007791D0 (en) | Novel compounds | |
| GB201020607D0 (en) | Novel compounds | |
| GB201019576D0 (en) | Novel compounds | |
| GB201019547D0 (en) | Novel compounds | |
| GB201019480D0 (en) | Novel compounds | |
| GB201019575D0 (en) | Novel compounds | |
| GB201014232D0 (en) | Novel compounds | |
| GB201014231D0 (en) | Novel compounds | |
| GB201014230D0 (en) | Novel compounds | |
| GB201012924D0 (en) | Novel compounds | |
| GB201012922D0 (en) | Novel compounds | |
| GB201010516D0 (en) | Novel compounds | |
| GB201010512D0 (en) | Novel compounds | |
| GB201010509D0 (en) | Novel compounds | |
| GB201010508D0 (en) | Novel compounds | |
| GB201010513D0 (en) | Novel compounds | |
| GB201010514D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230414 |